Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
TOC Section
Date
Availability
1-6 of 6
Keywords: TAK1
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Kazuhito Sai, Aoi Nakanishi, Kimberly M. Scofield, Debra A. Tokarz, Keith E. Linder, Todd J. Cohen, Jun Ninomiya-Tsuji
Journal:
Journal of Cell Science
J Cell Sci (2023) 136 (6): jcs260102.
Published: 13 March 2023
... and glutamate aberrantly activates neuronal TAK1 (also known as MAP3K7), which promotes the pathogenesis of AD in mouse models. Glutamate-induced Ca 2+ influx shifts TNF signaling to hyper-activate TAK1 enzymatic activity through Ca 2+ /calmodulin-dependent protein kinase II, which leads to necroptotic cellular...
Includes: Supplementary data
Journal Articles
Kazuhito Sai, Sho Morioka, Giichi Takaesu, Nagendran Muthusamy, H. Troy Ghashghaei, Hiroshi Hanafusa, Kunihiro Matsumoto, Jun Ninomiya-Tsuji
Journal:
Journal of Cell Science
J Cell Sci (2016) 129 (9): 1855–1865.
Published: 1 May 2016
..., including metabolic disorders. TAK1 (also known as MAP3K7) is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family and is activated by a diverse set of inflammatory stimuli. Here, we demonstrate that TAK1 regulates ER stress and metabolic signaling through modulation of lipid...
Includes: Supplementary data
Journal Articles
Lin Gao, Tzong-jen Sheu, Yufeng Dong, Donna M. Hoak, Michael J. Zuscik, Edward M. Schwarz, Matthew J. Hilton, Regis J. O’Keefe, Jennifer H. Jonason
Journal:
Journal of Cell Science
J Cell Sci (2013) 126 (24): 5704–5713.
Published: 15 December 2013
...Lin Gao; Tzong-jen Sheu; Yufeng Dong; Donna M. Hoak; Michael J. Zuscik; Edward M. Schwarz; Matthew J. Hilton; Regis J. O’Keefe; Jennifer H. Jonason Summary TAK1 is a MAP3K that mediates non-canonical TGF-β and BMP signaling. During the embryonic period, TAK1 is essential for cartilage and joint...
Includes: Supplementary data
Journal Articles
Raffaele Strippoli, Ignacio Benedicto, Miguel Foronda, Maria Luisa Perez-Lozano, Sara Sánchez-Perales, Manuel López-Cabrera, Miguel Ángel del Pozo
Journal:
Journal of Cell Science
J Cell Sci (2010) 123 (24): 4321–4331.
Published: 15 December 2010
... increasing expression of Twist. Nuclear translocation and transcriptional activity of p65 NF-κB, an important inducer of EMT, was increased by p38 inhibition. Moreover, p38 inhibition increased the phosphorylation of TGF-β-activated kinase 1 (TAK1), NF-κB and IκBα. The effect of p38 inhibition on E-cadherin...
Includes: Supplementary data
Journal Articles
Journal:
Journal of Cell Science
J Cell Sci (2009) 122 (15): 2651–2661.
Published: 1 August 2009
.... Co-immunoprecipitation experiments showed that XIAP, Siva1 and TAK1 form a ternary complex in Jurkat T cells. Reporter-gene analysis revealed that Siva1 inhibits XIAP- and TAK1-TAB1-mediated NFκB activation. By contrast, Siva1 increased XIAP- and TNFα-mediated AP1 activity and prolonged TNFα-induced...
Includes: Supplementary data
Journal Articles
Journal:
Journal of Cell Science
J Cell Sci (2000) 113 (6): 911–919.
Published: 15 March 2000
.... At various levels the Wnt pathway is subject to cross-regulation by other components. Recent evidence suggests that a specific MAP kinase pathway involving the MAP kinase kinase kinase TAK1 and the MAP kinase NLK counteract Wnt signalling. In particular, homologues of TAK1 and NLK, MOM-4 and LIT-1...